The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated analysis of real-world treatment outcomes of first-line axitinib plus pembrolizumab in patients with advanced renal cell carcinoma in the United States.
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb/Medarex; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Janssen; Myovant Sciences; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Anna Vlahiotis
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gordon Siu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Dharanija Rao
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Rosemary Teresi
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Anthony Eccleston
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer